RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients
Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to assess the efficacy and safety of the combination of
RAL+ATV/r in comparison with TDF/FTC+ATV/r in HIV-1 infected patients presenting virologic
failure and PI and TDF naïve.